Previous
Guingamp
AS Nancy Lorraine
5:00 PM UTC Mar 31, 2017
Game Details
Derby County
Queens Park Rangers
6:45 PM UTC Mar 31, 2017
Game Details
Espanyol
Real Betis
6:45 PM UTC Mar 31, 2017
Game Details
Toronto FC
Sporting Kansas City
11:30 PM UTC Mar 31, 2017
Game Details
Seattle Sounders FC
Atlanta United FC
2:00 AM UTC Apr 1, 2017
Game Details
Veracruz
Cruz Azul
3:00 AM UTC Apr 1, 2017
Game Details
Next

Transfer Rater: Ozil to Man United

Transfers
Read

Best fit for Bakayoko?

Transfers
Read

Transfer Rater: James to join Liverpool

Transfers
Read

Mangala has Man City medical - report

Porto centre-back Eliaquim Mangala appears to be closing in on a move to Manchester City after he was pictured at Manchester airport having reportedly undergone a medical.

- LIVE: Transfer Talk

Mangala, 23, who is expected to cost City 40 million euros, has been a long-term target for the club. They first bid for him at the end of the January transfer window, although a move could not be agreed upon then.

There were reports that the France international was spotted on Saturday at Manchester's Bridgewater Hospital, where City often take prospective signings for medicals.

Mangala and Roma's Mehdi Benatia were the two defenders at the top of City's shortlist this summer.

They allowed one central defender, Joleon Lescott, to leave when his contract expired, and only have three specialists in the position -- captain Vincent Kompany, Martin Demichelis and Matija Nastasic.

Mangala, who was an unused member of France's World Cup squad, has also been linked with Chelsea and Manchester United.

City have already made one signing from Porto this summer, bringing in midfielder Fernando for 15 million euros.

They have also signed former Arsenal right-back Bacary Sagna on a free transfer and goalkeeper Willy Caballero from Malaga.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.